Anthropic’s Claude AI Expands into Life Sciences Research and Drug Development
Artificial intelligence company Anthropic is adapting its Claude chatbot specifically for life sciences research and pharmaceutical development. Early adopters including Novo Nordisk and Sanofi have reported dramatic reductions in documentation time and widespread employee adoption of the AI tools.
Anthropic Targets Life Sciences with Specialized Claude AI
Artificial intelligence startup Anthropic is customizing its Claude chatbot specifically for researchers and life sciences companies, according to reports, as technology groups race to develop specialized applications from artificial intelligence technology. The San Francisco-based company reportedly announced on Monday that it is integrating Claude into scientific tools that researchers already use, including laboratory management systems, genomic analysis platforms, and biomedical databases.
